Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Blastic Phase Chronic Myelogenous Leukemia Clinical Trials References presented on Clinical Trials Search is not meant to be a substitute for certified health advice, travels to or professional assistance with a real medical. We are not physicians. Always consult your dr. about Blastic Phase Chronic Myelogenous Leukemia conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Blastic Phase Chronic Myelogenous Leukemia Clinical research trials and Blastic Phase Chronic Myelogenous Leukemia healthcare trials happen in hundreds of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectualness of new does drugs. The function of the studies / projects is to answer certain human medical questions. Clinical trials are a popular manner for mDs, government agencies, and private sector corporations to find treatments for all varieties of conditions, like Blastic Phase Chronic Myelogenous Leukemia. Blastic Phase Chronic Myelogenous Leukemia Clinical Trials and other clinical trials permit volunteers to obtain health treatment alternatives before they are available to the masses. Most times the participants acquire professional assistance for free of charge, and every now and again they are paid for their time. Sometimes there is a cost for a Blastic Phase Chronic Myelogenous Leukemia clinical trial. Participants oftentimes obtain the most effective healthcare available for their Blastic Phase Chronic Myelogenous Leukemia problem. Hazards are a reality, nevertheless, and could include extra or frequent mD trips, health dangers (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.

Home > Clinical Trials by Conditions > "B" Clinical Trial Conditions > Blastic Phase Chronic Myelogenous Leukemia Clinical Trials

Blastic Phase Chronic Myelogenous Leukemia Clinical Trials



3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

Adoptive Immunotherapy and Interleukin-2 in Treating Patients With Recurrent Accelerated or Blast Phase Chronic Myelogenous Leukemia After Undergoing Allogeneic Stem Cell Transplantation
Condition: fred_hutchinson_cancer_research_center_clinical_trials.html
Fred Hutchinson Cancer Research Center

Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
Condition: rush_cancer_institute_at_rush_university_medical_center_clinical_trials.html
Rush Cancer Institute at Rush University Medical Center

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Condition: memorial_sloankettering_cancer_center_clinical_trials.html
Memorial Sloan-Kettering Cancer Center

Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
Condition: h_lee_moffitt_cancer_center_and_research_institute_clinical_trials.html
H. Lee Moffitt Cancer Center and Research Institute

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers
Condition: university_of_maryland_greenebaum_cancer_center_clinical_trials.html
University of Maryland Greenebaum Cancer Center

Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia
Condition: childrens_oncology_group_clinical_trials.html
Children's Oncology Group

Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia
Condition: medical_college_of_pennsylvania_hospital_clinical_trials.html
Medical College of Pennsylvania Hospital

Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
Condition: memorial_sloankettering_cancer_center_clinical_trials.html
Memorial Sloan-Kettering Cancer Center

Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer
Condition: massey_cancer_center_clinical_trials.html
Massey Cancer Center

Fludarabine and Total-Body Irradiation Followed By Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate
Condition: fred_hutchinson_cancer_research_center_clinical_trials.html
Fred Hutchinson Cancer Research Center

Homoharringtonine in Treating Patients With Chronic Myelogenous Leukemia
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia
Condition: barbara_ann_karmanos_cancer_institute_clinical_trials.html
Barbara Ann Karmanos Cancer Institute

Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia
Condition: childrens_oncology_group_clinical_trials.html
Children's Oncology Group

Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia
Condition: shire_pharmaceutical_development_clinical_trials.html
Shire Pharmaceutical Development

VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies
Condition: vion_pharmaceuticals_clinical_trials.html
Vion Pharmaceuticals



Blastic Phase Chronic Myelogenous Leukemia Clinical Trials

Modify your Search

Blastic Phase Chronic Myelogenous Leukemia Clinical Trials by State:

California
Colorado
District Of Columbia
Florida
Georgia
Illinois
Indiana
Iowa
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Nebraska
New Jersey
New York
North Carolina
North Dakota
Ohio
Oregon
Pennsylvania
Tennessee
Texas
Utah
Virginia
Washington
Wisconsin

Other "B" Clinical Trials Conditions:

B Cell Leukemia
B Cell Lymphoma
B-Cell Adult Acute Lymphoblastic Leukemia
B-Cell Childhood Acute Lymphoblastic Leukemia
B-Cell Chronic Lymphocytic Leukemia
B-Cell Lymphoma
Back Injuries
Back Pain
Bacteremia
Bacterial Infection
Bacterial Infections
Bacterial Vaginosis
Balo's Concentric Sclerosis
Bare Lymphocyte Syndrome
Barrett's Esophagus
Basal Cell Ca
Basal Cell Carcinoma
Basal Cell Carcinoma Of The Skin
Basal Cell Nevus Syndrome
Basaloid Carcinoma Of The Anus
Becker Muscular Dystrophy
Behavior Disorders
Behavior Therapy
Behcet's Syndrome
Benign And Malignant Solitary Pulmonary Nodules
Benign Prostatic Hyperplasia
Benign Prostatic Hypertrophy
Bereavement
Beta Thalassemia
Beta-Oxidation Disorder
Beta-Thalassemia
Bifunctional Enzyme Deficiency
Bile Duct Cancer
Bile Duct Diseases
Biliary Atresia
Biliary Tract Diseases
Binge Eating Disorder
Bipolar Disorder
Bipolar Disorders
Bipolar I Disorder
Birth Defects
Bladder Ca
Bladder Cancer
Bladder Neoplasms
Blast Crisis
Blastic Phase Chronic Myelogenous Leukemia
Blastomycosis
Bleeding In The Brain
Blepharitis
Blepharospasm
Blindness
Blood Coagulation Disorder
Blood Coagulation Disorders
Blood Component Removal
Blood Disease
Blood Donors
Blood Platelets
Blood Transfusion
Bloom Syndrome
Body Dysmorphic Disorder
Body System/site Cancer
Body Weight Changes
Bone Avascular Necrosis
Bone Cancer
Bone Disease
Bone Disease, Metabolic
Bone Diseases
Bone Diseases, Metabolic
Bone Marrow Ablation
Bone Marrow Transplantation
Bone Metastases
Bony/soft Tissue Sarcoma
Borderline Personality Disorder
Botulism
Bph
Brain Cancer
Brain Concussion
Brain Disease
Brain Disorder
Brain Hemorrhage
Brain Injuries
Brain Injury
Brain Ischemia
Brain Mapping
Brain Metastases
Brain Neoplasm
Brain Neoplasms
Brain Tumor
Brain Tumors
Brainstem Tumor
Breast
Breast Ca
Breast Cancer
Breast Cancer In Situ
Breast Diseases
Breast Neoplasm
Breast Neoplasms
Breast Neoplasms - Phase I
Breast Reconstruction Surgery
Brenner Tumor
Bronchiectasis
Bronchiolitis Obliterans
Bronchitis
Bronchitis, Chronic
Bronchoalveolar Cell Lung Cancer
Bronchogenic Carcinoma
Bronchopulmonary Dysplasia
Brown-Sequard Syndrome
Bulimia
Bulimia Nervosa
Burkitt Lymphoma
Burkitt's Lymphoma
Burning Mouth Syndrome
Burns


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103